Literature DB >> 12759201

Abuse liability assessment of CNS drugs: conclusions, recommendations, and research priorities.

.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12759201     DOI： 10.1016/s0376-8716(03)00103-0

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN： 0376-8716            Impact factor:   4.492


× No keyword cloud information.
  5 in total

Review 1.  Abuse Potential of Pregabalin: A Systematic Review.

Authors:  Ole Schjerning; Mary Rosenzweig; Anton Pottegård; Per Damkier; Jimmi Nielsen
Journal:  CNS Drugs       Date:  2016-01       Impact factor: 5.749

Review 2.  Nicotine self-administration research: the legacy of Steven R. Goldberg and implications for regulation, health policy, and research.

Authors:  Jack E Henningfield; Tracy T Smith; Bethea A Kleykamp; Reginald V Fant; Eric C Donny
Journal:  Psychopharmacology (Berl)       Date:  2016-10-21       Impact factor: 4.530

3.  Conference on abuse liability and appeal of tobacco products: conclusions and recommendations.

Authors:  Jack E Henningfield; Dorothy K Hatsukami; Mitch Zeller; Ellen Peters
Journal:  Drug Alcohol Depend       Date:  2011-03-03       Impact factor: 4.492

Review 4.  Abuse liability assessment of tobacco products including potential reduced exposure products.

Authors:  Lawrence P Carter; Maxine L Stitzer; Jack E Henningfield; Rich J O'Connor; K Michael Cummings; Dorothy K Hatsukami
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-12       Impact factor: 4.254

5.  Pharmacodynamic and pharmacokinetic assessment of electronic cigarettes, combustible cigarettes, and nicotine gum: implications for abuse liability.

Authors:  Mitchell F Stiles; Leanne R Campbell; Donald W Graff; Bobbette A Jones; Reginald V Fant; Jack E Henningfield
Journal:  Psychopharmacology (Berl)       Date:  2017-06-20       Impact factor: 4.530
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.